A

Alnylam Pharmaceuticals

Biotechnology Research · United States · 5,000 employees

699 Decision makers
+91 New (6 months)
5,000 Employees
$4.8B Revenue
2002 Founded

Organizational Chart of Alnylam Pharmaceuticals

Roles identified within Alnylam Pharmaceuticals's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Alnylam Pharmaceuticals's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Alnylam Pharmaceuticals by function

General management

Marketing

Finance

Human resources

See all Alnylam Pharmaceuticals contacts on Zeliq

Decision makers at Alnylam Pharmaceuticals

699 identified 21 C-Level 52 VP 626 Directors +91 new (6 months)
See them on Zeliq →

Departments actively hiring 11 departments

Consulting
General management
Marketing
Medical
Operations
Other
Product
Project management
Research
Sales
Trades

These departments at Alnylam Pharmaceuticals are actively recruiting: a strong signal to time your outreach.

Funding and news at Alnylam Pharmaceuticals

Funding

Last round Other · $661M
Total funding $5.1B (12 rounds)
Corporate Round N/A Jan 2002
Series B $16M Aug 2002
Private Equity Round $25M Jul 2003
Post-IPO Equity $10M Mar 2011
Post-IPO Equity $700M Jan 2014
Post-IPO Equity $450M Jan 2015
Post-IPO Equity $800M Apr 2019
Post-IPO Debt $750M Apr 2020
Post-IPO Equity $250M Apr 2020
Post-IPO Debt $900M Sep 2022
Post-IPO Debt $500M Sep 2025
Post-IPO Debt $661M Oct 2025

Latest news at Alnylam Pharmaceuticals

  1. Appointment

    New Associate Director, Program Management appointed — Project management

  2. Appointment

    New Regional Business Director appointed — General management

  3. Appointment

    New Market Access Director appointed — Marketing

  4. Appointment

    New Executive Director, Biostatistics appointed — Research

  5. Appointment

    New Director, Strategic Pricing & Contracting appointed — Finance & accounting

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
445
Hiring Medical
347
Hiring Other
300
Hiring Sales
285
Hiring Operations
229
Hiring General Management
189
Technical
121
Finance
109

How to prospect Alnylam Pharmaceuticals's departments

Research

The company's largest department (445 people), currently in an active hiring phase. Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Medical

A team of 347 people, currently hiring. Time with patients is the priority: position your solution as a way to give hours back to care.

Other

This 300-person department is actively recruiting. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Sales

Hiring is underway in this team of 285 people. These profiles handle outreach daily and respond well to concrete pitches about pipeline, productivity and prospecting tooling.

Operations

A team of 229 people, currently hiring. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

General Management

This 189-person department is actively recruiting. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Try the Zeliq email finder demo →

FAQ Alnylam Pharmaceuticals

Who runs Alnylam Pharmaceuticals?

The highest-ranking leadership role identified at Alnylam Pharmaceuticals is “Associate Director”, based on public data updated 25 Oct 2026.

How many decision makers does Alnylam Pharmaceuticals have?

699 decision makers identified, including 21 at executive level.

How do I contact a decision maker at Alnylam Pharmaceuticals?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Alnylam Pharmaceuticals?

Consulting, General management and Marketing, based on published job offers as of 25 Oct 2026.

Companies similar to Alnylam Pharmaceuticals

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a company active in the Biotechnology Research space, based in United States. The company was founded in 2002 and has a workforce of roughly 5,000 people. Alnylam Pharmaceuticals belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Alnylam Pharmaceuticals is a B2B company, primarily serving business clients and professional organisations. Alnylam Pharmaceuticals has raised funding across 12 rounds totalling $5.1B. Annual revenue is estimated at around $4.8B. Sales teams can rely on this profile to qualify Alnylam Pharmaceuticals, spot business signals, and connect with verified decision makers.

Activity & Market

Alnylam Pharmaceuticals is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Alnylam Pharmaceuticals primarily serves business clients and professional organisations. The company is categorised as “Public company”.